Skip to main content

Table 2 Primary outcomes at 1-year follow-up

From: Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study

 

SGLT2i (n = 1100) (%)

Metformin (n = 39,920) (%)

Hazard ratio (95% CI)

p value

Heart failure hospitalization

0.63

1.26

0.47 (0.41–0.54)

 < 0.0001

Acute coronary syndrome

0.35

0.66

0.50 (0.41–0.61)

 < 0.0001

Ischemic stroke

2.53

2.01

1.21 (1.10–1.32)

 < 0.0001

All-cause mortality

1.05

1.95

0.49 (0.44–0.55)

 < 0.0001

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840